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Recombinant therapeutic proteins are increasingly important to the 
pharmaceutical industry. Global spending on biologics, such as anti-
bodies, hormones and blood factors, reached $138 billion dollars in 
2010 (ref. 1). CHO cell lines are the preferred host expression system 
for many therapeutic proteins2, and the cells have been repeatedly 
approved by regulatory agencies. Moreover, they can be easily cultured 
in suspension and can produce high titers of human-compatible 
therapeutic proteins3.
Most improvements in CHO-based recombinant protein titer and 
quality have been achieved by random cell-line mutagenesis and 
media optimization4. Meanwhile, efforts to engineer mouse cells have 
greatly benefited from numerous genomic tools and technologies, 
owing in large part to the availability of the Mus musculus reference 
genome sequence. Genomic resources are also becoming available for 
CHO cells, such as the CHO-K1 genome5, expressed sequence tag6,7 
and bacterial artificial chromosome (BAC) libraries8, and compen-
dia of proteomic9–11 and transcriptomic data7,12–16. However, much 
like how murine cell line data are routinely studied in the context of 
the Mus musculus reference genome, there is a need for a standard 
reference for all CHO cell lines to contextualize all of these valuable 
genomic resources.
Many recombinant protein–producing CHO cell lines were derived 
from the CHO-K1, CHO-S and DG44 lineages. Each has undergone 
extensive mutagenesis and clonal selection17. Hence, a standard ref-
erence genome that is representative of the genomic sequence of all 
native CHO genes and regulatory elements would be advantageous for 
the successful implementation of genomic resources in CHO-based 
bioprocessing4,17. To address this need, we present a draft genome 
sequence of the C. griseus (Chinese hamster) colony from which the 
CHO cell lines have been derived. This reference sequence is used to 
analyze the genomic composition and mutational diversity among 
seven CHO cell lines, and to study how sequence variations may affect 
cellular processes that are of bioprocessing relevance. The C. griseus 
genome may serve along with the previously published CHO-K1 
genome as primary reference resources in future analyses of omics 
data sets derived from CHO cells. This will also aid in bioprocessing 
systems analysis and in cell line engineering studies.
RESULTS
Genome assembly
Female Chinese hamster DNA was acquired from various tissues and 
sequenced using the Illumina HiSeq 2000 platform, yielding 347.5 Gb 
of raw data (Supplementary Tables 1 and 2). Using SOAPdenovo, we 
assembled 2.4 Gb of the genome with a contig N50 (the shortest length 
of sequence contributing more than half of assembled sequences) 
of 26.5 kb and scaffold N50 of 1.54 Mb (Table 1). The genome was 
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further assembled into super-scaffolds with optical mapping, yield-
ing an N50 of 2.49 Mb. Ninety percent of the genome assembly was 
included in the 1,091 longest super-scaffolds (Table 1). The overall 
size of the hamster genome was estimated to be 2.7 Gb using the 
k-mer estimation method (Supplementary Fig. 1). Optical mapping 
data were further combined with published BAC-based fluorescence 
in situ hybridization data8 to successfully associate 26% of the genome 
sequence data to specific hamster chromosomes (Supplementary 
Tables 3 and 4).
To assess the coverage of the hamster transcripts in the assembly, 
we sequenced mRNA from a pool of hamster tissues and assembled 
the transcriptome de novo into 98,116 contigs (Online Methods). 
Mapping RNA-seq contigs to the genome assembly demonstrated that 
>90% of the assembled transcripts could be associated with annotated 
genes (Supplementary Table 5).
Genome annotation
We annotated repeat features and identified endogenous retroviral 
elements (Supplementary Notes and Supplementary Tables 6–9). 
We next predicted genes using homology-based approaches, 
de novo gene prediction algorithms and transcriptome-based methods 
(Supplementary Table 10 and Supplementary Fig. 2). The final 
gene set consisted of 24,044 genes in the hamster genome, which 
is similar to that of the CHO-K1 cell line5. Of these predicted 
genes, 23,473 clustered into 21,628 gene families (Fig. 1a), and 
3,052 (14.1%) gene families contained more than one gene in the 
hamster. Only 20 gene families were unique to the hamster, when 
compared to the rat, mouse and CHO-K1 genomes (Fig. 1b). We 
functionally annotated 82% (19,775) of the predicted genes using 
InterPro, Swiss-Prot, TrEMBL, Gene Ontology (GO) and KEGG 
(Supplementary Table 11).
Comparison between hamster and CHO-K1 genomes
Mutations and structural variations are common in mammalian cell 
line genomes17–19. Although large chromosomal rearrangements 
have been shown in CHO cell lines previously8, the extent of these 
changes at the sequence level remains unknown. Thus, we compared 
the structure and gene content of the Chinese hamster genome and 
the published genome of CHO-K1 cells from the American Type 
Culture Collection (ATCC)5. To facilitate this comparison, we aligned 
all large hamster and CHO-K1 scaffolds to the mouse chromosomes. 
Numerous chromosomal translocations have occurred through evo-
lution since the mouse and hamster diverged (Fig. 2a). However, 
no large sections of the mouse chromosomes were missing in the 
hamster (Fig. 2b). On the other hand, CHO-K1 scaffolds failed to 
align to portions of mouse chromosomes 5, 7, 15 and 19 (Fig. 2b). 
Meanwhile, Illumina sequencing reads from CHO-K1 (ref. 5) aligned 
to the hamster scaffolds corresponding to these regions. This result 
suggests the possibility that these regions are in CHO-K1, albeit 
considerably mutated or rearranged. We next directly assessed the 
scope of mutations by comparing the CHO-K1 genome to the hamster 
genome. CHO-K1 contained 25,711 structure variations, including 
13,735 insertions and 11,976 deletions (Supplementary Notes and 
Supplementary Table 12). Despite the large number of structural 
variations in CHO-K1, the set of annotated genes in the hamster 
and CHO-K1 were highly similar. Specifically, there was a 99% over-
lap in gene content between the two genomes, and an assessment 
of GOslim terms for these genes confirmed the similarity in gene 
content (Fig. 2c).
Variation between different CHO cell lines
Despite the similarity in gene content, numerous genomic varia-
tions were detected in CHO-K1 relative to the hamster. To elucidate 
Table 1 Assembly statistics
Contig Scaffold Super-scaffolds
Size (bp) Number Size (bp) Number Size (bp) Number
N90 6,390 91,476 346,540 1,637 443,523 1,091
N80 11,724 65,207 656,362 1,156 939,760 723
N70 16,531 48,549 950,835 853 1,417,091 519
N60 21,461 36,190 1,249,430 634 1,994,221 378
N50 26,761 26,456 1,544,832 461 2,491,721 271
Longest (bp) 219,443 – 8,324,132 – 10,797,402 –
Total size (bp) 2,332,459,831 – 2,393,115,851 – 2,400,585,184 –
Total number (≥100 bp) – 458,620 – 287,210 – 286,619
Total number (≥2 kb) – 128,107 – 6,947 – 6,356
Nx contig (scaffold) size is the length of the smallest contig (scaffold) S in the sorted list of all contigs (scaffolds) where the cumulative length from the largest contig to contig S 
is at least x% of the total assembly length.
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Figure 1 Gene families across C. griseus and 
several mammalian genomes. (a) The majority 
of mammalian genes are orthologous, with 
more than 5,000 preserved as single copies 
in each species (dark blue). A few thousand 
have species-specific duplications (light 
blue), whereas other orthologs were shared by 
only some of the nine mammals studied here 
(orange). A small fraction of genes were unique 
to just one species (green), and occasionally 
had paralogs in that one species (pink). (b) The 
overlap of orthologous gene clusters is shown 
among the CHO-K1, C. griseus, M. musculus 
and Rattus norvegicus genomes. ENSEMBL 
(v58) annotated genes were used for the CHO-K1,  
M. musculus and R. norvegicus genomes.
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the extent of genomic heterogeneity across 
other cell lines, we sequenced six additional 
CHO cell lines (Fig. 3a) to >9× depth, cov-
ering ~95% of each genome. Including the 
previously sequenced CHO-K1 genome, the 
seven cell lines accounted for three different 
lineages and several different phenotypic fea-
tures, for example, cells adapted to different 
media, suspension-grown cells and antibody-
producing cells (Supplementary Table 13).
To initially validate our cell line resequencing data, we inspected 
the genotype related to an important phenotypic marker for CHO cell 
lines. Certain cell lines lack dihydrofolate reductase (DHFR) activ-
ity20, and cannot grow without glycine, hypoxanthine and thymidine 
(GHT). However, when an exogenous DHFR gene is coupled to a 
gene encoding a desired protein product on the same plasmid, the 
GHT media and methotrexate can be used to select for clones that 
overproduce DHFR and the recombinant protein of interest. Among 
the cell lines sequenced here, only the DG44 cell line is known to carry 
the DHFR-negative phenotype20. Consistent with this characteristic, 
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Figure 2 Genome comparison between mouse, 
Chinese hamster and CHO-K1. Conserved 
sequences among the mouse, CHO-K1 and  
C. griseus genomes were determined by aligning 
their scaffolds (larger than 1 Mb) to the mouse 
genome. (a) Assignment of C. griseus scaffolds 
to M. musculus chromosomes. The C. griseus 
scaffolds with chromosomal assignment 
(accounting for more than a quarter of the  
2.4 Gb of genomic sequence) were compared 
to mouse chromosomes to assess the scale of 
chromosomal rearrangement. (b) Alignment of 
CHO-K1 and C. griseus genomes. Few large DNA 
stretches are missing in the hamster, whereas 
there are more regions to which CHO-K1 
scaffolds could not align. (c) Gene annotation. 
The number of genes was determined for each 
“Biological Process” GO slim category in both 
the C. griseus and CHO-K1 genomes.
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all cell lines had genomic sequence data for 
the DHFR gene, except for DG44 (Fig. 3b). 
This DG44-specific deletion was further con-
firmed by PCR (Fig. 3c).
To assess the genome-wide differences 
between these CHO cell lines, we used the 
hamster genome assembly as the reference sequence. This reference 
sequence allowed us to determine SNPs, short insertions and deletions 
(indels) and gene copy number variations (CNVs) (Supplementary 
Table 14). Across the cell lines, we identified 3,715,639 SNPs, and a 
phylogenetic reconstruction based on these SNPs accurately recapitu-
lated the cell line history (Fig. 3d). We also identified 551,240 indels 
shorter than 5 bp, 319 of which are predicted to be frame-shifting indels 
in coding regions. SNPs and indels did not occur uniformly, and some 
hamster chromosomes were more affected than others (Fig. 3e,f).
We also found 3,383 nonredundant duplicated regions in at 
least one cell line and 177 duplicated regions in all seven cell lines 
(Supplementary Table 15). In total, 4,241 genes resided entirely 
within these 3,383 duplicated regions. Moreover, 113 genes were 
found to have a reduced copy number in one or more cell lines. 
In addition, 17 hamster genes were completely missing in at least one 
cell line, and the missing genes often differed between the lineages 
(Supplementary Table 16).
A variety of genes are associated with mutations and CNVs 
(Supplementary Tables 17–20). Of the SNPs, 5,487 (0.15%) were 
nonsynonymous and significantly enriched in many GO classes (false 
discovery rate < 0.01), such as olfactory genes and G protein–coupled 
receptors (P < 2 × 10−25 and 6 × 10−21, respectively; hypergeomet-
ric test), whereas genes in these same classes were rarely duplicated 
(P < 1 × 10−5 and 0.02, respectively; hypergeometric test). In addi-
tion, proteins involved in cell adhesion were also enriched in SNPs 
(P < 0.004; hypergeometric test). It is possible that these mutations influ-
ence the ability of  CHO cells to grow in suspension cultures without 
adhesion factors.
Other genes were protected from SNPs, such as genes associated 
with DNA binding transcription factor activity and metabolism 
(P < 0.006 and P < 9 × 10−5, respectively; hypergeometric test). 
Notably, some signaling pathways were insulated from SNPs, such 
as the WNT and mTOR signaling pathways (P < 0.02 and P < 0.002, 
respectively; hypergeometric test) and autophagy (P < 0.01). These 
pathways all contribute to the proliferative and immortalized pheno-
types in cancer cells21–23 and likely play a similar role in CHO cell 
lines. Protein glycosylation was also significantly insulated from 
SNPs in all cell lines (mean hypergeometric P = 0.018). Thus, the 
distribution of mutations and CNVs seems consistent with traits 
that make CHO cell lines desirable protein production hosts 
(that is, high proliferation rate, suspension growth and protected 
protein glycosylation).
Using the genome to study the apoptosis pathway
CHO production strains can be grown to high cell densities in fed-
batch cultures with serum-free media. Bioprocessing limitations in 
nutrients in these environments can lead to apoptosis, thereby lim-
iting viable cell density and volumetric productivity. To improve 
bioprocessing efficiencies, many researchers have sought to improve 
cell-line longevity by suppressing apoptosis in CHO cells. These 
efforts involve modulating protein activity by overexpressing anti-
apoptotic pathways24 and blocking pro-apoptotic pathways with 
chemicals25, short interfering RNA (siRNA)26 and gene deletions27. 
However, the complex nature of apoptosis has made it nontrivial to 
optimize in CHO cells. Thus, a more complete view of gene expression 
and mutations in the apoptosis system could facilitate bioprocessing 
and cell engineering efforts to control cell death.
To assess changes in apoptosis in CHO cells, we first identified 
homologs for anti- and pro-apoptotic proteins in the C. griseus 
genome (Supplementary Table 21). Of the 62 KEGG orthologous 
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aFigure 4 Expression changes and CNVs of key 
members of the apoptotic pathways. Apoptosis 
is a complex network of proteins that integrates 
several external and internal signals to make 
decisions about programmed cell death. (a) On 
average, gene expression levels of pro-apoptotic 
genes are only slightly lower in CHO-K1, in 
comparison to the Chinese hamster. However, 
anti-apoptotic gene expression is significantly 
higher in CHO-K1 (*: P < 0.02, Wilcoxon  
rank-sum test). (b) When assessing expression 
of individual genes, pro-apoptotic genes (red) 
tend to more frequently decrease mRNA 
expression, whereas anti-apoptotic genes (blue) 
more frequently increase expression. (c) Many 
major pro-apoptotic (red) and anti-apoptotic 
(blue) proteins are represented here in the 
context of the extrinsic (brown), intrinsic (red) 
or survival (blue) pathways. Proteins that have 
CNVs are plotted in bar graphs with each bar 
representing a unique cell line as detailed in 
the legend, and copy numbers are normalized to 
the copy number in hamster. Thus, a value less 
than one suggests a loss of a gene copy, whereas 
a value greater than one suggests duplication. 
Details on each gene abbreviation are included 
in Supplementary Table 21.
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gene identifiers in apoptosis, 92% were in the hamster genome. 
Consistent with observations in mouse, caspase-10 was missing28. 
Other missing genes included interleukin-3, interleukin-3 receptor 
alpha and interleukin-1 alpha. Although these genes were undetected, 
apoptosis utilizes redundant pathways, and the lack of these genes 
should not hinder the system.
In the CHO-K1 cell line, no additional genes for anti- and pro-
apoptotic proteins were lost relative to the hamster. Instead, apoptotic 
gene expression significantly changed. Pro-apoptotic genes exhibited 
slightly lower gene expression in CHO-K1 in comparison to C. griseus, 
although this was not statistically significant. However, anti-apoptotic 
genes in CHO-K1 exhibited significantly higher median expres-
sion (P < 0.02; Wilcoxon rank-sum test; Fig. 4a). Apoptotic genes 
with the greatest increase in expression tended to be anti-apoptotic 
(e.g., NF-κB, protein kinase A, Akt and Bcl-XL), whereas repressed 
genes tended to be pro-apoptotic (e.g., endonuclease G, IκBα, BAX, 
and p53) (Fig. 4b). Thus, CHO-K1 suppresses apoptosis, and we 
anticipate that similar gene expression changes occur in other CHO 
cell lines.
In addition to changes in apoptotic gene expression, CNVs also 
frequently occur in apoptotic genes in mammalian cell lines29. As 
CNVs can complicate efforts to engineer cell lines, we also analyzed 
CHO CNVs in the context of the apoptosis pathways.
The apoptotic network is stimulated by external signals through the 
extrinsic pathway, or internal stress signals (e.g., increases in cytosolic 
Ca2+ or DNA damage) through the intrinsic pathway. The diverse sig-
nals transmitted by each pathway converge upon the caspase proteases, 
which cleave protein targets and lead to cell death28. As a strategy 
to increase CHO cell longevity, caspase activation has been targeted 
with chemical inhibitors30 and caspase-inhibiting proteins24,31–33. 
We found that several cell lines contained extra copies of various 
caspases (Fig. 4c). Thus, efforts to remove pro-apoptotic genes, such 
as caspases, should account for potential CNVs for those genes. Some 
anti-apoptotic genes were duplicated only in individual cell lines, 
which may lead to these lines being more resilient against apopto-
sis activation. For example, the inhibitors of apoptosis (IAP) family 
of proteins inhibit caspases34, and we found that one IAP gene, BIRC7, 
is duplicated in all cell lines. In addition, another anti-apoptotic 
factor, phosphoinositide 3-kinase (PI3K), also showed cell type– 
specific CNVs.
In general, CNVs occur in various pathways, such as apoptosis and 
glycosylation (Supplementary Fig. 3) and can differ between cell 
lines (Supplementary Tables 22 and 23). Knowledge of CNVs can 
help researchers avoid unexpected genomic changes35–37 when using 
nucleases in duplicated regions. CNVs can be clone-specific as gene 
copy numbers in a single cell line vary considerably during growth 
media adaptation or after several cell passages29,38. Thus, clone-
 specific genomic data may indicate which cell line modifications will 
be effective in developing a particular production cell line.
DISCUSSION
Genomic resources have provided a wealth of tools in biotechnology4, 
ranging from phenotyping tools, such as transcriptomics, to genome 
editing technologies. These resources have transformed our ability 
to study and modify the functions of human cells (e.g., cancer and 
human embryonic kidney cells) and other model organisms. Similar 
tools are becoming available for CHO cells16,39,40, but maximizing 
their potential requires a clear picture of the genomic landscape of 
CHO cells. Here, we demonstrated how the C. griseus genome can 
provide a sequence-level view of genomic heterogeneity between cell 
lines and yield a more comprehensive picture of the variants in a cell 
line of choice.
Numerous studies have shown large chromosomal rearrangements 
in CHO cells, using banding techniques41–43 and fluorescence in situ 
hybridization8,44–48. These approaches identified large translocations 
in CHO cells, providing a coarse-grained view of genomic varia-
tions in these unstable genomes. We present, for the first time to our 
knowledge, a whole-genome, sequence-level view of the heterogene-
ity between CHO cell lines. We showed that each cell line harbors 
a unique set of mutations, including SNPs, indels, CNVs and miss-
ing genes. CNVs were particularly heterogeneous, with 48% (mostly 
duplications) being unique to one cell line (Supplementary Table 16). 
We also found that mutations rapidly accumulate during development 
of production cell lines. For example, during the development of the 
C0101 antibody-producing cell line from CHO-S, 301,753 new SNPs 
arose, representing 9% of the SNPs in that cell line.
The nonuniform distribution of mutations in each cell line seemed 
to have some phenotypic relevance. Indeed, several processes asso-
ciated with proliferation and immortalized phenotypes were more 
insulated from mutation. These included the WNT and mTOR 
signaling pathways and processes such as autophagy. Mutations 
in other pathways such as glycosylation and viral susceptibility 
(Supplementary Notes) varied between cell lines and might influ-
ence desired phenotypic properties, although careful biochemical 
studies are needed. Duplications were also seen for many apop-
totic genes. Notably, many of the sequence variations were shared 
between members of the same family of CHO cells (that is, CHO-
K1, DG44 or CHO-S), but these were frequently not shared across 
CHO cell families (Supplementary Tables 16 and 22–24). A detailed 
knowledge of mutations in each cell line may be valuable for cell 
line selection, characterization and engineering, as well as bioproc-
ess and media optimization. This knowledge for each cell line may 
further improve the success of siRNAs, zinc finger nucleases and other 
cell-line engineering tools. Additionally, as more sequence variation 
data are collected on diverse cell lines, it may be possible to associate 
cell phenotypes with different mutations (as is commonly done in 
model organisms49).
To fully detail the sequence variations, it is necessary to have a 
well-defined reference genome with relevance to all CHO cell lines. 
The reference genome should exhibit several properties. First, it 
must contain the genomic sequence of all native CHO genes and 
their regulatory elements. We found that CHO-K1 seems to be miss-
ing certain hamster genes, and that cell lines from other lineages are 
missing other genes (Supplementary Table 16). Although we focused 
on genes that are entirely missing, many more truncated genes and 
disrupted promoter elements may be found in each cell line as gene 
models are improved and as regulatory elements are discovered.
Second, it is often desirable to identify all variants in a cell line, 
and not just the genomic differences between two cell lines. There are 
clear ultrastructural differences between the hamster and CHO cells. 
Some chromosomal translocations are conserved among cell lines8. 
These structural variations are likely conserved because CHO cells 
from the CHO-K1, DG44 and CHO-S lineages share a common highly 
mutated ancestor. Indeed, we found that 67% of SNPs (~2.5 million) 
were shared among all CHO cell lines. These shared variants would 
be missed if the CHO-K1 genome were used as the sole reference. 
Mutations with deleterious effects on expression and/or activity can 
be more comprehensively cataloged using the hamster genome as the 
reference. Thus, endemic loss-of-function mutations in CHO could be 
identified and remedied as needed for a desired phenotype.
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Third, a reference genome must be amenable to improvement over 
time. The chromosomes of CHO cell lines are unstable, with nonneg-
ligible karyotypic differences even in the same culture17,43. Thus, it 
will be much easier to develop and maintain a gold standard reference 
sequence of the more stable Chinese hamster genome. This resource 
will be valuable for characterizing CHO cell lines and using omic 
technologies, akin to how the M. musculus genome is used for study-
ing murine cell lines. Furthermore, although regulatory challenges 
remain for cell line engineering, whole-genome resequencing against 
a reference genome will provide transparency as regulatory agencies 
assess products from engineered cell lines for approval.
There are important differences in genomic content among CHO 
cell lines that can influence cell line traits. These are likely to be fur-
ther influenced by differences in gene expression levels. As a result, 
genome-scale viewpoints will likely become increasingly relevant for 
CHO-based bioprocessing, as they have for microbe-based manufac-
turing over the past decade. Although these approaches can require 
expensive phenotyping and omic technologies, costs are rapidly 
decreasing. Thus, genome-scale analyses may enhance our ability to 
understand the production characteristics of CHO cell lines and aid 
in the production of therapeutic proteins in the coming decades.
METHODS
Methods and any associated references are available in the online 
version of the paper.
Accession codes. GenBank: AMDS00000000; the version described 
in this study is AMDS00000000.1. Accession codes for the sequenc-
ing data for the cell lines and the hamster transcriptome are listed in 
Supplementary Table 25.
Note: Supplementary information is available in the online version of the paper.
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ONLINE METHODS
Sample preparation and DNA sequencing. Female Chinese hamsters were 
kindly provided by G. Yerganian. Genomic DNA was isolated from multiple tis-
sues using a modified SDS method50. Seven different paired-end libraries were 
constructed with 170 bp, 500 bp, 800 bp, 2 kb, 5 kb, 10 kb and 20 kb insert sizes, 
using the standard protocol provided by Illumina (San Diego). The sequenc-
ing was done using Illumina HiSeq 2000 according to the manufacturer’s 
standard protocol. The raw data were filtered to remove low-quality reads, 
reads with adaptor sequences, and duplicated reads before de novo genome 
assembly (Supplementary Notes).
Optical mapping. High molecular weight DNA was obtained from Chinese 
hamster tissues. Whole genome shotgun, single-molecule restriction maps 
were generated using the automated Argus system (OpGen Inc., Maryland, 
USA), based on the optical mapping technology51,52. Individual DNA mol-
ecules were deposited onto silane-derivatized glass surfaces in MapCards 
(OpGen Inc., MD, USA) and digested by BamHI enzyme. DNA was subse-
quently stained with JOJO fluorescence dye (Invitrogen, CA, USA) and imaged 
within the Argus system. A total of 28 MapCards were processed. The DNA 
molecules were marked up and restriction fragment size was determined 
by image processing in parallel with image acquisition. This yielded ~26×  
optical data.
Genome assembly. Similar to the assembly of the CHO-K1 genome, SOAPdenovo 
v.1.06 (ref. 53) was used to assemble the hamster genome into contigs and scaf-
folds as well as for gap closure. The final genome assembly was 2.4 Gb in length, 
which is about 89% of the estimated genome. The contig N50 (the shortest 
length of sequence contributing more than half of assembled sequences) was 
26.5 kb and the scaffold N50 was 1.54 Mb (Table 1 for statistics on genome 
assembly). Optical mapping data were used to further assemble the genome 
into super-scaffolds. The scaffolds were extended according to the optical maps 
to determine overlapping regions between scaffolds and their relative loca-
tion and orientation. First, the sequence scaffolds were converted into restric-
tion maps by in silico restriction enzyme digestion by BamHI. These in silico 
restriction maps were used as seeds to identify single-molecule restriction 
maps of DNA from the corresponding genomic regions by map-to-map align-
ment. These single-molecule maps were then assembled together by using the 
in silico maps, to produce elongated consensus maps (extended scaffolds). The 
low coverage regions near the ends of the extended scaffolds were trimmed off 
to maintain high extension quality. To generate sufficient extension length, we 
repeated the alignment-assembly process 4–5 times, using the extended scaf-
folds as seeds for each subsequent iteration. All of the extended scaffolds were 
then aligned to each other. Any pair-wise alignments above an empirically 
decided confidence threshold were considered as initial candidates for scaffold 
connection. Alignments that overlapped substantially with the initial scaffolds 
were excluded from the candidates. Among the remaining alignments, those 
with the highest score were considered. The relative location and orientation 
of each pair of connected scaffolds were used to generate super-scaffolds. This 
resulted in 6,356 super-scaffolds (>2 kb) with N50 of 2.49 Mb (Table 1).
Chromosomal assignment of scaffolds. To assign scaffolds to their respec-
tive chromosomes, our optical mapping data were used in conjunction with 
published BAC end-sequencing and fluorescence in situ hybridization8. 
Specifically, chromosomal assignments were obtained for each BAC, and then 
blastn was used to find scaffolds with the highest homology to the BAC end-
sequences (E-value < 1 × 10−5). Scaffolds aligned to BACs from more than one 
chromosome were filtered from the analysis. Once chromosomal assignments 
were obtained for scaffolds (Supplementary Table 3), they were extended to 
super-scaffolds based on optical mapping data (Supplementary Table 4). From 
this analysis, we were able to reliably localize 26% of the genomic sequence to 
specific hamster chromosomes.
RNA sequencing and assembly. RNA was isolated from eight tissues from 
several Chinese hamsters. Total RNA was extracted using Trizol (Invitrogen, 
USA). The isolated RNA was then treated by RNase-free DNase. The RNA 
was subsequently mixed and treated using the Illumina mRNA-Seq Prep Kit 
following the manufacturer’s instructions. The insert size of the RNA libraries 
was about 170 bp, and the sequencing was done using Illumina HiSeq 2000. 
Raw reads were filtered out if they contained contamination or were of low 
quality (more than 10% of the bases with unknown quality). The resulting 5 Gb 
of RNA-seq data were assembled into transcriptional fragments by Trinity54 
(version: r2011-08-20). We then assessed the coverage of the transcripts in the 
genome assembly by mapping the assembled transcriptional fragments to the 
genome assembly using BLAT55.
Gene annotation. We predicted gene models using de novo, homology-based 
and transcriptome-aided prediction approaches. For de novo gene prediction, 
we used a repeat-masked genome assembly. We used AUGUSTUS (version 
2.03)56, GlimmerHMM (version 3.02) and Genscan (version 1.0) for de novo 
gene annotation. For homology-based prediction, we mapped the protein 
sequences from the CHO-K1 cell line using BLAT, with an E-value cutoff of 
10−2, followed by Genewise57 (version 2.2.0) for gene annotation. Genes with 
less than 70% identity and 80% coverage in the BLAT alignment were filtered. 
Transcriptome-aided annotation was done by mapping all RNA-seq reads back 
to the reference genome using Tophat58 (version 1.3.3), implemented with 
bowtie59 (version 0.12.5). The transcripts were assembled using Cufflinks60  
(version 1.2.1). Taken together with the assembled transcripts from Cufflinks, 
we identified the genomic regions covered by the transcriptome. De novo genes 
with less than 50% coverage in the transcriptome data were filtered. Finally, 
the nonredundant gene sets were merged with the homology-based method 
genes and de novo genes, while filtering transposable element genes identified 
in the functional annotation. Gene functions were assigned according to the best 
match of the alignments using blastp (E-value ≤ 10−5) against the Swiss-Prot 
and UniProt databases (release 15.10). The motifs and domains of genes were 
determined by InterProScan61 (version 4.5) against protein databases. Gene 
Ontology IDs for each gene were obtained from the corresponding InterPro 
entry. All genes were aligned against KEGG (release 48.2) proteins, and the 
pathway in which the gene might be involved was derived from the matching 
genes in KEGG. If the best hit of a gene was “function unknown,” “putative,” 
etc., the second best hit was used to assign function until there were no more 
hits meeting the alignment criteria (then this gene would be annotated as func-
tionally unknown). Repeat features, transposible elements and endogenous ret-
roviral genes were also identified and annotated (Supplementary Notes and 
Supplementary Figs. 4 and 5).
Genome comparison. The assembled Chinese hamster and CHO-K1 scaf-
folds (>1 kb) were masked by RepeatMasker to remove repeat elements. The 
repeat-masked mouse genome62 was downloaded from ENSEMBL (release 
60). The repeat-masked hamster and the CHO-K1 assemblies were aligned 
to the mouse genome as previously described63. The LASTZ pair-wise whole 
genome alignment software (http://www.bx.psu.edu/miller_lab/dist/README.
lastz-1.02.00/README.lastz-1.02.00a.html) was used with the parameters: 
K = 4,500 l = 3,000 Y = 15,000 E = 150 H = 0 O = 600 T = 2. The Chain/Net 
package64 was subsequently used to process the alignment. With the ham-
ster chromosomal assignments (Supplementary Fig. 6) for many scaffolds, 
comparisons on chromosomal localization were made between the mouse and 
hamster (Fig. 2a, Supplementary Notes and Supplementary Fig. 7). Structural 
variations between the hamster and CHO-K1 genomes were found using a 
procedure previously applied to compare two human genomes65. Large masked 
scaffolds (larger than 1 megabase in length) were processed with LASTZ using 
the aforementioned parameter set. These alignments between the hamster and 
CHO-K1 were corrected for inaccurately predicted gaps in the assembly and 
other alignment errors. Using the corrected alignments, the best match for each 
location on the CHO-K1 scaffolds was chosen by the option “axtBest.” This 
deploys a dynamic programming algorithm using the same substitution matrix 
as used during the alignment. The hits that contributed most to the colinearity 
between the large scaffolds of the Chinese hamster and CHO-K1 were selected, 
and discrepancies between the aligned sections were called as insertions and 
deletions, exhibiting a wide range of lengths (Supplementary Fig. 8).
Detection of sequence variation among cell lines. We sequenced six different 
CHO cell lines to assess the extent of genomic divergence from the hamster 
genome. The cell lines were grown on their respective media (Supplementary 
Table 13), after which their DNA was harvested and sequenced to greater 
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than the minimum recommended depth of 9× for each cell line, to assure 
that enough coverage was obtained to resolve heterozygous SNPs. Sequencing 
data can be obtained from the NCBI short read archive (see Supplementary 
Table 25 for accession numbers).
Missing genes in the six resequenced cell lines and the previously sequenced 
CHO-K1 ATCC genome5 were detected as follows. Sequencing reads from 
the seven cell lines and hamster were mapped to hamster assembly with BWA 
(version 0.5.9). Read depth of genes was calculated using ‘depth’ tool of 
SAMtools (version 0.1.18). A gene was declared to be deleted if it conformed to 
the following criteria. First, when mapping the hamster reads to the assembled 
hamster genome scaffolds, the read depth of the gene had to be greater than 
half of the mean read depth across all hamster genes. Second, the read depth 
of the gene for a given cell line had to be less than 0.1. SOAPaligner (version 
2.21) was also used for a repeat trial. The resulting read depth distribution was 
consistent with that derived from BWA.
To detect SNPs, indels and CNVs, the raw reads from each cell line were 
mapped to the hamster genome assembly to determine sequence variations. To 
aid the process of variant detection, the hamster scaffolds were concatenated in 
a random fashion to obtain 12 pseudo chromosomes. SOAP was used to align 
the sequencing reads from each cell line to the reference hamster assembly. 
The alignments were subsequently split into pseudochromosomes and sorted 
according to the mapped position. SOAPsnp was used to identify SNPs in 
each cell line. To further refine the predicted SNPs, we adopted an alternative 
approach using BWA to align the reads to the hamster assembly. The ‘mpileup’ 
tool of SAMtools was applied to get the information of each genomic posi-
tion in the different samples and BCFtools in the same package was used for 
variant calling. The two SNP data sets were subsequently combined to make 
the final SNP data set. For each library, we filtered SNPs with depth less than 
half of the mean depth. We also filtered SNPs that were located within 5 bp 
of another SNP. In total, we identified 3,715,639 SNPs. SNPs were used to 
reconstruct the phylogeny of the CHO cell lines. The Jukes-Cantor pairwise 
distance was computed between all strains and the phylogenetic tree was built 
using the unweighted pair group method average. The alignments were further 
processed using SOAPindel (http://soap.genomics.org.cn/soapindel.html) to 
identify indels and analyzed using CNVnator to detect CNVs66.
Nonsynonymous SNPs, frame-shifting indels, and gene-containing CNVs 
were identified and analyzed. The hypergeometric test was used to identify 
gene classes that were over- or under-represented in mutations in all Gene 
Ontology classes and KEGG pathways, based on our genome annotation 
(Supplementary Tables 17–20). More detailed analysis on apoptotic pathways 
was based on KEGG ortholog assignments (Supplementary Table 21). 
Additional analysis on glycosylation and viral succeptability genes 
(Supplementary Notes and Supplementary Fig. 9) were based on homology 
to gene lists published previously5 (Supplementary Notes and Supplementary 
Tables 26 and 27).
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